A detailed history of Dunhill Financial, LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Dunhill Financial, LLC holds 5 shares of BIO stock, worth $1,664. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 3 66.67%
Holding current value
$1,664
Previous $703,000 125.18%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$263.97 - $344.64 $527 - $689
2 Added 66.67%
5 $1.58 Million
Q2 2024

Aug 09, 2024

BUY
$268.26 - $339.48 $268 - $339
1 Added 50.0%
3 $703,000
Q4 2023

Feb 12, 2024

BUY
$269.37 - $365.04 $538 - $730
2 New
2 $593,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.2B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.